1.Effect of Evaluation Method on Quality of Prescription
Taoran ZHOU ; Deqiu ZHU ; Kaiming WANG
China Pharmacy 2007;0(34):-
OBJECTIVE:To investigate the effect of evaluation method on management of prescription. METHODS:A total of 24 000 prescriptions of 12 months were evaluated with both method 1 devised by our hospital and method 2 specified in ordinance of Management of prescription. The administration department intervened physicians’ prescription behaviors according to the evaluation results. The change of data in method 1 was compared with that in method 2. RESULTS: In method 1,the problems of usage and dosage increased a little while other irrational problems lessened largely. In method 2,the average amount of drug categories reduced a little while the other data increased a little. CONCLUSION: The effect of evaluation and intervention in method 1 are superior to those in method 2.
2.Participation of Clinical Pharmacists in the Therapy for a Case of AECOPD Complicated with Pulmonary In-fection
Guangzhi BAO ; Lulu TIAN ; Taoran ZHOU ; Deqiu ZHU
China Pharmacy 2015;(32):4584-4585,4586
OBJECTIVE:To investigate the role of clinical pharmacists in the therapy for acute exacerbation of chronic obstruc-tive pulmonary diseases (AECOPD) complicated with pulmonary infection. METHODS:Clinical pharmacists participated in the therapy for a case of acute exacerbation of AECOPD complicated with pulmonary infection. According to the patients’signs,assis-tant examination and disease condition,clinical pharmacists provided suggestions,i.e. Piperacillin sodium and sulbactam sodium for injection (4∶1) 5.0 g,ivgtt,q12 h,for anti-infective treatment;Bisacodyl enteric-coated tablet 5 mg,po,qd,for promoting defecation;Clostridium butyricum viable bacteria tablet 20 mg,po,tid,for regulating gastrointestinal flora;Pinaverium bromide tablet 50 mg,po,tid,for regulating gastrointestinal smooth muscle tension;Shexiang baoxin pills 22.5 mg,po,tid,instead of flu-id infusion for protecting heart,and isosorbide 5-mononitrate 20 mg,po,tid,for preventing angina pectoris;Cefminox capsule 100 mg,po,tid,for anti-infective treatment;fluconazol 0.4 g,ivgtt,qd,for antifungal treatment,and Bacillus licheniformis 500 mg,po, tid,for preventing alteration of intestinal flora. RESULTS:The physicians adopted clinical pharmacist’s suggestions. No ADR was found during treatment,and the patients transferred to ordinary ward after the disease condition had been controlled. CONCLU-SIONS:The participating of clinical pharmacists in pharmaceutical care can promote rational drug use in the clinic and guarantee the safety of drug use.
3.Development and Application of the Kinematic Database Software of Lower Limbs Based on Internet
Hai ZHOU ; Taoran LIU ; Binghao WENG
Chinese Journal of Medical Instrumentation 2017;41(3):166-169
In current study, we develop a new kinematic database software for lower limbs based on internet. This article present technical features as well as functions of the software, further present the development idea and working process. This software can be used to store kinematic data of lower limbs in any motion state, and take data statistics, from macro perspectives, it works for doctors to improve the clinical treatment level and rehabilitation training, evaluate the motion ability of lower limb of patient, help industry and medical device manufacturers with lower limb prosthesis design, it also can provide technical support to the production's ergonomic design.
4.Analysis of Factors Influencing Progression-free Survival Time of Patients with Non-squamous Cell Carcinoma Type Non-small Cell Lung Cancer after First Chemotherapy
Shijing QIAN ; Taoran ZHOU ; Juan WU ; Deqiu ZHU
China Pharmacy 2018;29(4):520-525
OBJECTIVE: To investigate the factors that influence the progression-free survival time (PFS) of patients with non-squamous cell carcinoma type non-small cell lung cancer (NSCLC) after first chemotherapy, and to provide reference for the formulation of clinical individual treatment regimen. METHODS: Clinical information of 84 patients with non-squamous cell carcinoma type NSCLC after first chemotherapy were selected from our hospital during Jan. 2012-Dec. 2014. The effects of patient's factors [gender, age, performance status (PS) score], disease factors [tumor staging, tumor marker (TM) level] and treatment factors (chemotherapy regimen and treatment course, chemotherapy efficacy) on PFS were analyzed retrospectively. RESULTS: All patients were followed up for 11. 933 months averagely (final follow-up time of Jun. 30th, 2017), and their median PFS was 4. 017 months. The median PFS of male was slightly shorter than that of female; the median PFS of patients aged more than 65 year-old was slightly shorter than that of patients aged below 65 year-old; the median PFS of patients with PS score of 0-1 was slightly longer than that of patients with PS score of 2-4, without statistical significance (P>0. 05). The median PFS of Ⅱ -Ⅲ stage patients was significantly longer than that of Ⅳ stage patients; the median PFS of patients with at least one TM index was 10 times higher than the upper limit of the normal value was significantly shorter than that of patients with four TM indexes were all 10 times lower than the upper limit of the normal value; the median PFS of patients underwent 1-3 treatment courses was significantly shorter than that of patients underwent 4-6 treatment courses; the median PFS of patients with progressive disease efficacy was significantly shorter than that of patients with stable disease efficacy or above, with statistical significance (P<0. 05). Among 84 patients, 81 patients selected PP regimen (pemetrexed disodium+platinum), and other patients chose non-PP regimen. Due to the large difference in the number of cases, the effect of the chemotherapy regimen on the patient' s PFS was not investigated. CONCLUSIONS: The disease factor and treatment factor of patients may be associated with PFS. Tumor staging, at least one TM index was 10 times higher than the upper limit of the normal value, the number of completed chemotherapy treatment course, chemotherapy efficacy are independent influential factors of PFS in patients with non-squamous cell carcinoma type NSCLC.
5.Effects of nursing intervention combined with preventive medication on adverse reactions during FFA
Ying LIU ; Nalei ZHOU ; Taoran REN ; Junfang SHI ; Yuexian CUI ; Jianbin AN
Chinese Journal of Modern Nursing 2015;21(5):514-515,516
Objective To investigate the effects of nursing intervention combined with preventive medication on adverse reactions during fundus fluorescence angiography ( FFA ) . Methods From January 2012 to 2014, a total of 2 840 patients, who underwent FFA at the Second Hospital of Hebei Medical University for the first time, were randomly assigned to nursing intervention group, preventive medication group, combination group and control group, then we compared the type and ratio of adverse reactions to figure out the most efficient measurement. Results The ratio of systematic anaphylaxis reaction and adverse reaction of digestive system and adverse reactions of nervous system were 1. 5%,1. 4% and 1. 3% in the combination group, that both were lower than these in nursing intervention group, preventive medication group and control group (χ2 =82. 747, 8.128, 7.626,respectively;P <0. 05). Conclusions The combination of nursing intervention and preventive medication can efficiently minimize the occurrence of adverse reactions during FFA.
6.Musculoskeletal System Anatomic Database Software Applied to the Internet.
Hai ZHOU ; Taoran LIU ; Dongmei WANG
Chinese Journal of Medical Instrumentation 2019;43(4):248-251
We developed a new the musculoskeletal anatomic database software based on internet. This article presents the design objective and basic routes of the software, further present the technical plan, software functionality and service objects. This software is used to store the anatomic data of musculoskeletal system, that allows the users to enquire and do statistial analysis through the large amount of anatomic data, that guides the doctors to design operative schemes, that provides technical supports for medicine and industry fields.
Databases, Factual
;
Humans
;
Internet
;
Musculoskeletal System
;
Software
;
User-Computer Interface
7.Saponins in Treatment of Alzheimer's Disease and Their Mechanism of Action: A Review
Taoran LI ; Xiaoqing ZHOU ; Hongdong LIU ; Dongmei YAN ; Shan LIU ; Bin LI
Chinese Journal of Experimental Traditional Medical Formulae 2022;28(14):216-225
Alzheimer's disease(AD) is an irreversible neurodegenerative disease with clinical manifestations such as memory impairment, aphasia, impaired visuospatial skills, executive function impairment, and personality changes. AD has brought a heavy burden to the family and society due to its unrevealed pathogenesis and the lack of therapeutic approaches. Saponins, a group of oligoglycosides whose aglycones are triterpenes or spirosteroids, are divided into triterpene saponins and steroidal saponins, which have a variety of biological activities. At present, there is no systematic review on the anti-AD effect of saponins. According to the literature published in recent years, the authors summarized the studies of saponins in improving AD based on animal experiments. The results indicated that saponins enhanced learning ability and improved cognitive impairment by inhibiting amyloid β-protein (Aβ) cascade activity, suppressing microtubule-associated protein (tau) hyperphosphorylation, inhibiting neuronal oxidative stress, inhibiting inflammatory factors, regulating apoptosis, inhibiting cholinergic neuronal degeneration, promoting mitochondrial autophagy, regulating intestinal flora, and enhancing energy metabolism, which in turn improved the pathological state of AD animal models. The therapeutic effects of different saponins on AD are different. The present study discussed the effect of different aglycones and sugar chains on the anti-AD activity based on saponins and anti-AD effect to provide new ideas and a theoretical basis for the development and utilization of saponins.
8.Domestic self-expanding interventional pulmonary valve stent in transthoracic implantation for pulmonary valve regurgitation: A prospective cohort study
Ziqin ZHOU ; Taoran HUANG ; Naijimuding ABUDUREXITI ; Yong ZHANG ; Haiyun YUAN ; Nianjin XIE ; Hongwen FEI ; Hui LIU ; Jian ZHUANG ; Jimei CHEN ; Shusheng WEN
Chinese Journal of Clinical Thoracic and Cardiovascular Surgery 2024;31(09):1305-1312
Objective To analyze and summarize the early and medium-term outcomes of self-expanding interventional pulmonary valve stent (SalusTM) for right ventricular outflow tract dysfunction with severe pulmonary valve regurgitation. Methods We established strict enrollment and follow-up criteria. Patients who received interventional pulmonary valve in transthoracic implantation in Guangdong Provincial People’s Hospital from September 2, 2021 to July 18, 2023 were prospectively included, and all clinical data of patients were collected and analyzed. Results A total of 38 patients with severe pulmonary regurgitation were included, with 23 (60.5%) males and 15 (39.5%) females. The mean age was 24.08±8.12 years, and the mean weight was 57.66±13.54 kg. The preoperative mean right ventricular end-diastolic volume index (RVEDVI) and right ventricular end-systolic volume index (RVESVI) were 151.83±42.84 mL/m2 and 83.34±33.05 mL/m2, respectively. All patients successfully underwent transcatheter self-expandable pulmonary valve implantation, with 3 (7.9%) patients experiencing valve stent displacement during the procedure. Perioperative complications included 1 (2.6%) patient of postoperative inferior wall myocardial infarction and 1 (2.6%) patient of poor wound healing. The median follow-up time was 12.00 (6.00, 17.50) months. During the follow-up period, there were no deaths or reinterventions, and no patients had recurrent severe pulmonary regurgitation. Three (7.9%) patients experienced chest tightness and chest pain, and 1 (2.6%) patient developed frequent ventricular premature beats. Compared with preoperative values, the right atrial diameter, right ventricular diameter, and tricuspid annular plane systolic excursion were significantly reduced at 6 months and 1 year postoperatively, with improvement in the degree of pulmonary regurgitation (P<0.01). Compared with preoperative values, RVEDVI and RVESVI decreased to 109.51±17.13 mL/m2 and 55.88±15.66 mL/m2, respectively, at 1 year postoperatively (P<0.01). Conclusion Self-expanding interventional pulmonary valve in transthoracic implantation is safe and effective for severe pulmonary valve regurgitation and shows good clinical and hemodynamic results in one-year outcome.